As of 2026-02-04, DNA疫苗（酪氨酸酶相关蛋白2）'s data on the DeepSeek platform in the 抗肿瘤 DNA 疫苗新药研发 category shows: The overall mention rate is 0.00%, above the industry average by 0.0 percentage points, showing notable performance. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
DNA疫苗（酪氨酸酶相关蛋白2）'s Mention Rate is 0.00%, lower than 0.6% of competitors
DNA疫苗（酪氨酸酶相关蛋白2）'s First Mention is 0.00%, lower than 0.9% of competitors
DNA疫苗（酪氨酸酶相关蛋白2）'s Preferred Rate is 0.00%, lower than 100.0% of competitors
DNA疫苗（酪氨酸酶相关蛋白2）'s Positive Rate is 0.00%, lower than 8.9% of competitors
DNA疫苗（酪氨酸酶相关蛋白2）'s Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| DDNA疫苗（酪氨酸酶相关蛋白2） (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
